Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000870248 | SCV001011737 | likely benign | Alpha-1-antitrypsin deficiency | 2024-11-12 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000870248 | SCV001277339 | uncertain significance | Alpha-1-antitrypsin deficiency | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Prevention |
RCV004749497 | SCV005348597 | uncertain significance | SERPINA1-related disorder | 2024-08-21 | no assertion criteria provided | clinical testing | The SERPINA1 c.1069G>A variant is predicted to result in the amino acid substitution p.Val357Met. This variant was reported in an individual with Alpha-1-antitrypsin deficiency (Arora et al 2010. PubMed ID: 20453271; Giacopuzzi E et al 2018. PubMed ID: 29882371; Kueppers F et al 2019. PubMed ID: 31307431). This variant is reported in 0.34% of alleles in individuals of South Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |